Segment Reporting (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2025 USD ($) segment	Sep. 30, 2024 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			2
Segment Reporting Information [Line Items]
Impact of foreign currency fluctuations	$ 23	$ (14)	$ (39)	$ (73)
Net sales	5,065	4,209	14,788	12,186
Cost of products sold	1,413	1,250	4,289	3,694
Selling, general and administrative expenses	1,451	1,231	4,252	3,661
Research and development expenses	465	357	1,303	1,038
Other segment items	11	4	37	23
Segment operating incom	1,701	1,380	4,947	3,843
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments	(2,494)	(2,164)	(7,387)	(6,467)
Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs	(146)	(209)	(711)	(719)
Amortization expense	(225)	(205)	(669)	(631)
Operating income (loss)	1,048	733	2,788	1,928
Other income (expense), net	(110)	(65)	(103)	(231)
Income (loss) before income taxes	939	669	2,685	1,697
MedSurg
Segment Reporting Information [Line Items]
Net sales	1,722	1,479	5,015	4,373
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	3,343	2,731	9,773	7,813
Operating Segments
Segment Reporting Information [Line Items]
Net sales of reportable segments	5,041	4,224	14,827	12,259
Income (loss) before income taxes		669		1,697
Operating Segments | MedSurg
Segment Reporting Information [Line Items]
Net sales of reportable segments	1,714	1,484	5,027	4,396
Cost of products sold	$ 483	$ 412	$ 1,388	$ 1,193
Cost of products sold, percentage of net sale	28.20%	27.80%	27.60%	27.10%
Selling, general and administrative expenses	$ 531	$ 440	$ 1,557	$ 1,334
Selling, general and administrative expenses, percentage of net sale	31.00%	29.70%	31.00%	30.30%
Research and development expenses	$ 128	$ 113	$ 369	$ 335
Research and development expenses, percentage of net sale	7.50%	7.60%	7.30%	7.60%
Other segment items	$ 5	$ 0	$ 18	$ 9
Other segment items, percentage of net sale	0.30%	0.00%	0.40%	0.20%
Segment operating incom	$ 566	$ 518	$ 1,693	$ 1,525
Segment operating income, percentage of net sale	33.00%	34.90%	33.70%	34.70%
Operating Segments | Cardiovascular
Segment Reporting Information [Line Items]
Net sales of reportable segments	$ 3,327	$ 2,740	$ 9,801	$ 7,863
Cost of products sold	$ 930	$ 838	$ 2,901	$ 2,500
Cost of products sold, percentage of net sale	27.90%	30.60%	29.60%	31.80%
Selling, general and administrative expenses	$ 920	$ 791	$ 2,695	$ 2,327
Selling, general and administrative expenses, percentage of net sale	27.60%	28.90%	27.50%	29.60%
Research and development expenses	$ 337	$ 244	$ 934	$ 703
Research and development expenses, percentage of net sale	10.10%	8.90%	9.50%	8.90%
Other segment items	$ 6	$ 5	$ 18	$ 14
Other segment items, percentage of net sale	0.20%	0.20%	0.20%	0.20%
Segment operating incom	$ 1,135	$ 862	$ 3,253	$ 2,318
Segment operating income, percentage of net sale	34.10%	31.50%	33.20%	29.50%
Segment Reporting, Reconciling Item, Corporate Nonsegment
Segment Reporting Information [Line Items]
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments	$ (282)	$ (234)	$ (779)	$ (565)